Gelterkinden, Switzerland

Walter Vifian

This inventor holds 19 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 19 EPO patents, primarily in CNS Drug Development. Top assignees: Hoffmann-La Roche Inc., Remynd Nv. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Walter Vifian. Retrieved from https://idiyas.com/inventor/walter-vifian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19 

% Patents Active = 31.6

 

 

Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 23(Granted Patents)


Location History:

  • Olten, CH (2008)
  • Gelterkinden, CH (2012 - 2017)
  • Basel, CH (2019 - 2022)

Company Filing History:


Years Active: 2008-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Triazolo-Azepine Derivatives
Pyrimidine Derivatives
BACE1 Inhibitors
Piperazine Thiazole Derivatives
Oxytocin Receptor Agonists
Pyrrolidine Compounds
Neurodegenerative Diseases
Piperidine Derivatives
NK3 Receptor Antagonists
Quinazoline Derivatives
Spiropiperidine Derivatives
Thiadiazol-Piperazine Derivatives
19 patents (USPTO):Explore Patents

Title: Walter Vifian: Innovator in Pharmaceutical Compounds

Introduction

Walter Vifian is a notable inventor based in Gelterkinden, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating various neurological conditions. With a total of 19 patents to his name, Vifian's work has the potential to impact many lives.

Latest Patents

Among his latest innovations are the Triazolo-azepine derivatives. This invention relates to compounds that can be utilized in the treatment of Alzheimer's disease, cerebral amyloid angiopathy, hereditary cerebral hemorrhage with amyloidosis, Dutch-type (HCHWA-D), multi-infarct dementia, dementia pugilistica, and Down syndrome. Another significant contribution is his work on pyrimidine derivatives, which includes new compounds with various applications in pharmaceutical compositions and methods of use.

Career Highlights

Walter Vifian has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and Remynd NV. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development in the field.

Collaborations

Throughout his career, Vifian has collaborated with talented individuals such as Hasane Ratni and Matthias Heinrich Nettekoven. These partnerships have fostered innovation and have been instrumental in advancing his research.

Conclusion

Walter Vifian's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through scientific advancements. His work continues to pave the way for new treatments and therapies that can enhance the quality of life for many individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…